The FDA approved Regeneron's Otarmeni on April 23, making it the first gene therapy for inherited hearing loss — and Regeneron said it will make the treatment available at no cost to eligible patients...

The Food and Drug Administration on Thursday approved a gene therapy that can cure a rare, inherited form of deafness.